Posts by DAY Vision
Prestigious Cancer Centers Johns Hopkins and Moffitt Complete Patient Enrollment in Post Approval Study for MarginProbe®, Transforming the Standard of Care for Breast Cancer Patients
Dilon Devices has reached another milestone in their MarginProbe® Post Approval Study (PAS) as Johns Hopkins Hospital and Moffitt Cancer Center complete their patient enrollments for the trial.
Read MoreInnovative Breast Center Showcases New Strategies in the Fight Against Cancer
As part of their whole-person care strategy, Dr. Wilson’s practice uses a new tool, known as MarginProbe, to ensure that a safe margin of tissue is removed around a cancerous tumor as that tumor is removed during surgery.
Read More2018 Highlights in Developments in Breast Cancer Diagnosis and Treatment
With the year coming to an end we put together an overview of the many developments in breast cancer research and treatment from 2018.
Read MoreBreast Surgeon Dr. Dudak Reflects on Tremendous Changes in Breast Cancer Treatment in the Past 20 Years
“I think for breast cancer, every few months there’s something new and exciting,” the physician shared. “I think there’s always some new technology, new drugs, or new study that comes out that changes our outlook.”
Read MoreBreast Surgeon Breaks Barriers with Putting the Patient First
“I realized breast surgery put me in the operating room, which I love to do, but it also allowed me to take care of my patients hands-on and I could follow my patients practically forever,” explained Dr. Karen Karsif.
Read More